ADAPTIVE BIOTECHNOLOGIES (ADPT)

US00650F1093 - Common Stock

2.335  -0.1 (-4.3%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
170.28M185.30M154.30M98.40M85.10M
Minority Interest Expense
54.00K200.00K0.00N/AN/A
Cost Of Goods
75.55M57.90M49.30M22.50M22.30M
Gross Profit
94.72M127.40M105.00M75.90M62.80M
Operating Expenses
296.33M326.00M314.00M228.70M141.20M
Research and Development
122.12M122.70M142.30M116.10M70.70M
Selling, General, and Administrative Expenses
172.51M183.20M170.00M110.90M68.80M
Operating Income
-201.61M-198.60M-209.00M-152.80M-78.40M
Interest Income/Expense
1.73M-200.00K1.70M6.60M9.80M
Non Recurring Items
-25.43M-1.60MN/AN/A0.00
Income Before Taxes
-225.30M-200.40M-207.30M-146.20M-68.60M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-225.25M-200.20M-207.30M-146.20M-69.60M
EBITDA
-179.38M-177.70M-195.00M-144.30M-70.60M
 
Per Share Data
EPS Diluted Total Ops
-1.56-1.40-1.48-1.11-0.56
Non GAAP EPS
-1.38-1.41-1.47-1.11N/A
 
Statistics
Gross Profit Margin
55.63%68.75%68.05%77.13%73.80%
Profit Margin
-132.29%-108.04%-134.35%-148.58%-81.79%
Operating Profit Margin
-118.40%-107.18%-135.45%-155.28%-92.13%

All data in USD

Charts